Page last updated: 2024-10-30

maprotiline and Kidney Failure, Chronic

maprotiline has been researched along with Kidney Failure, Chronic in 2 studies

Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukunishi, I1
Kitaoka, T1
Shirai, T1
Watanabe, S1
Kennedy, SH1
Craven, JL1
Rodin, GM1
Roin, GM1

Trials

1 trial available for maprotiline and Kidney Failure, Chronic

ArticleYear
Major depression in renal dialysis patients: an open trial of antidepressant therapy.
    The Journal of clinical psychiatry, 1989, Volume: 50, Issue:2

    Topics: Aged; Antidepressive Agents; Clinical Trials as Topic; Depressive Disorder; Desipramine; Humans; Kid

1989

Other Studies

1 other study available for maprotiline and Kidney Failure, Chronic

ArticleYear
Cardiac arrest caused by maprotiline in an elderly hemodialysis patient.
    Nephron, 1998, Volume: 78, Issue:2

    Topics: Aged; Antidepressive Agents, Tricyclic; Female; Heart Arrest; Humans; Kidney Failure, Chronic; Mapro

1998